technetium-tc-99m-pyrophosphate has been researched along with Ischemia* in 11 studies
1 review(s) available for technetium-tc-99m-pyrophosphate and Ischemia
Article | Year |
---|---|
Hyperbaric oxygen reduces ischemia-induced skeletal muscle injury.
The effect of hyperbaric oxygen treatment on skeletal muscle submitted to 3 or 4 hours of ischemia was studied in a rat hindlimb model after 48 hours of reperfusion. Forty-eight male Sprague-Dawley rats were allocated to four groups. In the two treatment groups, hyperbaric oxygen was given for 45 minutes at 2.2 atm immediately and 4,8,16,24,32, and 40 hours after release of the ischemia-inducing tourniquet. The injury to skeletal muscle was quantified from the uptake of 99mtechnetium-pyrophosphate (injected intravenously after 45 hours of reperfusion) in anterior tibial muscle harvested 3 hours later. The uptake was significantly lower in hyperbaric oxygen-treated rats than in untreated rats with 3 or 4 hours of ischemia (p < 0.01 and P < 0.05). After 4 hours of ischemia, the changes in levels of the intracellular muscle compounds adenosine triphosphate, phosphocreatine, and lactate were less in the hyperbaric oxygen-treated rats than in the untreated animals. Topics: Animals; Biopsy; Disease Models, Animal; Hyperbaric Oxygenation; Ischemia; Male; Muscle, Skeletal; Radionuclide Imaging; Random Allocation; Rats; Rats, Sprague-Dawley; Technetium Tc 99m Pyrophosphate; Time Factors | 1996 |
10 other study(ies) available for technetium-tc-99m-pyrophosphate and Ischemia
Article | Year |
---|---|
Skeletal muscle fiber type does not predict sensitivity to postischemic damage.
Because the three distinct fiber types of skeletal muscle have significant metabolic differences, the predominant fiber type in a muscle may influence its sensitivity to injury from ischemia and reperfusion. The few studies to address this issue have been conflicting. We explored possible differences in the sensitivity of fiber types to ischemia/reperfusion injury with an isolated rat hindlimb preparation perfused with an albumin-enriched Krebs buffer. Following 120 min of ischemia and 60 min of reperfusion, the tibialis anteriorwhite, tibialis anteriorred, soleus, and plantaris muscles were assessed for injury by examining three parameters: skeletal muscle injury (via 99Tc-pyrophosphate), microvascular injury (via 125I-albumin), and tissue water content. There was no consistent correlation between fiber type and sensitivity to postischemic injury. Both the soleus (slow twitch) and plantaris (fast twitch) muscles sustained similar significant injury: muscle damage was 133 and 167% greater than controls, and microvascular damage 96 and 91% greater than controls, respectively. However, other fast twitch muscles (tibialis anteriorwhite and tibialis anteriorred) exhibited no significant injury. Both injured muscles were in the posterior compartment while the uninjured muscles were in the anterior compartment. Regional flow as measured by microspheres revealed no correlation between postischemic flow and muscle injury, microvascular injury, or compartmental location. Skeletal muscle fiber type was not consistently predictive of its sensitivity to ischemia/reperfusion-induced injury. Compartmental location may have played an as yet unknown role in modulating vulnerability to postischemic damage. Topics: Animals; Body Water; Capillary Permeability; Ischemia; Male; Microcirculation; Microspheres; Muscles; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Reperfusion Injury; Serum Albumin, Radio-Iodinated; Technetium Tc 99m Pyrophosphate | 1992 |
Quantification of skeletal muscle necrosis in the lower extremities using 99Tcm pyrophosphate with single photon emission computed tomography.
No non-invasive quantitative method is currently available for measuring the amount of regional skeletal muscle necrosis in humans. A threshold method using 99Tcm pyrophosphate (PPi) with single photon emission computed tomography (SPECT) has been reported to quantify muscle necrosis successfully in a canine model. This method has been modified to measure muscle necrosis in the lower extremities of human patients. Modifications include adding background subtraction and using the contralateral unaffected lower extremity as background region. A region of interest was also manually drawn around the affected lower extremity muscle to exclude the tibia. In order to identify the group of patients with no significant necrosis and with diffuse hyperaemia, nine control subjects were studied. The variance of the counts within the pixels of the lower extremities was 132 (S.D. = 27). A variance of greater than 159 was considered as being significant for necrosis. Thirteen patients were studied. Six patients had significant muscle necrosis (462 ml, S.D. = 280 ml). All except one patient (who had a small amount of muscle necrosis) developed foot drop. Seven patients had no significant necrosis. All patients had normal ankle dorsiflexion. It is possible to quantify regional muscle necrosis using PPi with SPECT. Volume of necrosis determined by this method can also predict clinical outcome. Topics: Aged; Female; Humans; Ischemia; Leg; Male; Middle Aged; Muscles; Necrosis; Technetium Tc 99m Pyrophosphate; Tomography, Emission-Computed, Single-Photon | 1992 |
Iloprost attenuates the increased permeability in skeletal muscle after ischemia and reperfusion.
Increased vascular permeability is an early and sensitive indicator of ischemic muscle injury, occurring before significant histologic or radionuclide changes are evident. We investigated the effect of iloprost, a stable prostacyclin analog, on microvascular permeability in a rat striated muscle model. In six control and six experimental animals the cremaster muscle was dissected, placed in a closed-flow acrylic chamber, and suffused with a bicarbonate buffer solution. Dextran labeled with fluorescein was injected intravenously as a macromolecular tracer, and microvascular permeability was determined on the basis of clearance of the fluorescent tracer. Two hours of ischemia were followed by 2 hours of reperfusion. In the experimental group iloprost (0.5 microgram/kg/min) was given in a continuous intravenous infusion. Microvascular permeability increased significantly during reperfusion in both control and experimental animals (p less than 0.0001). Treatment with iloprost, however, significantly attenuated this response compared to the control group, 4.8 +/- 0.3 versus 7.3 +/- 0.5 microliters/gm/min, respectively (p less than 0.0001). Iloprost decreases the rise in vascular permeability after ischemia and reperfusion. Experimental clinical use of iloprost under controlled conditions in the treatment of patients with acute skeletal muscle ischemia appears justified. Topics: Animals; Capillary Permeability; Diphosphates; Iloprost; Ischemia; Male; Microcirculation; Muscles; Radionuclide Imaging; Rats; Rats, Inbred WF; Reperfusion; Technetium; Technetium Tc 99m Pyrophosphate; Time Factors | 1990 |
Sustained benefit of temporary limited reperfusion in skeletal muscle following ischemia.
Limiting the rate of reperfusion blood flow following prolonged ischemia in skeletal muscle has been shown beneficial. However, the persistence of this benefit with reinstitution of normal blood flow remains undefined. We investigated the role of temporary limited reperfusion on ischemia-reperfusion injury in an isolated gracilis muscle model in six anesthetized dogs. Both gracilis muscles were subjected to 6 hr of ischemia followed by 2 hr of reperfusion. Reperfusion blood flow was limited for the first hour in one gracilis muscle to its preischemic rate followed by a second hour of normal reperfusion (LR/NR). The contralateral muscle underwent 2 hr of normal reperfusion (NR/NR). Muscle injury was quantified by technetium-99m pyrophosphate (TcPyp) uptake and by histochemical staining using triphenyltetrazolium chloride (TTC) with planimetry of the infarct size. Capillary permeability was evaluated by muscle weight gain. Results are reported as the mean +/- SEM: [table: see text] These data demonstrate a sustained benefit from temporary limited reperfusion. This methodology should be considered in the surgical management of the acutely ischemic limb. Topics: Animals; Blood Flow Velocity; Blood Pressure; Diphosphates; Dogs; Female; Histocytochemistry; Ischemia; Kinetics; Male; Muscles; Organ Size; Reperfusion Injury; Technetium; Technetium Tc 99m Pyrophosphate; Tetrazolium Salts; Time Factors | 1990 |
Quantitation of postischemic skeletal muscle necrosis: histochemical and radioisotope techniques.
Skeletal muscle necrosis will result from prolonged periods of ischemia. The purpose of this study was to develop a method to estimate the extent of necrosis using nitroblue tetrazolium staining and technetium scanning. The bilateral canine gracilis muscle preparation with total vascular isolation was exposed to 4 hr of complete normothermic ischemia followed by reperfusion. After 45 hr of reperfusion 99mTc pyrophosphate (PYP) was injected and 3 hr later the muscles were harvested, cut into six slices, and stained with nitroblue tetrazolium. Biopsies were taken from tetrazolium-positive and -negative areas for electron microscopy to confirm the ability of the stain to distinguish viable from necrotic muscle. Computerized planimetry of the staining pattern was used to estimate the extent of necrosis as a percentage of the total muscle. Electron microscopy confirmed the validity of nitroblue tetrazolium to discriminate between viable and necrotic skeletal muscle in this experimental model. After 4 hr of ischemia the percentage necrosis was 30.2 +/- 6.1% (mean +/- SEM, n = 12), there was no difference in the extent of necrosis in left vs right paired muscles, using tetrazolium staining or technetium PYP uptake. There was a statistically significant correlation between the percentage necrosis and the density of 99mTc PYP uptake per muscle (r = 0.83, P less than 0.001) and per slice (r = 0.94, P less than 0.001). This study demonstrates the ability of tetrazolium staining to accurately differentiate between viable and necrotic skeletal muscle and provides a reproducible method for estimating the extent of necrosis in the gracilis muscle model. Topics: Animals; Diphosphates; Dogs; In Vitro Techniques; Ischemia; Muscles; Necrosis; Nitroblue Tetrazolium; Radionuclide Imaging; Staining and Labeling; Technetium; Technetium Tc 99m Pyrophosphate | 1988 |
Technetium 99m pyrophosphate quantitation of skeletal muscle ischemia and reperfusion injury.
The study of ischemia and reperfusion injury in the extremity has been hampered by lack of an accurate method of measuring skeletal muscle injury. We used a bilateral isolated in vivo canine gracilis muscle model in 15 anesthetized dogs. The experimental muscles had 4, 6, or 8 hours of ischemia and 1 hour of reperfusion. The contralateral gracilis muscle served as a control. Technetium 99m pyrophosphate (99mTc-PYP), an agent which localizes in injured muscle cells, was used to quantitate canine skeletal muscle damage. After 6 hours of ischemia and 1 hour of reperfusion, there was a significant increase of 215% of 99mTc-PYP uptake in the experimental vs the control muscle. Experimental muscle uptake was 8% greater than control after 4 hours and 405% more after 8 hours of ischemia and reperfusion. Segmental distribution of 99mTc-PYP uptake showed localization to be greatest in the middle of the muscle at the entry site of the gracilis artery. Electron microscopic evaluation also documented this area to have undergone the most severe injury. Distal portions of the muscle did not show increased damage. Our results show that 99mTc-PYP effectively quantitates skeletal muscle ischemia and reperfusion injury. The pattern of 99mTc-PYP uptake suggests that considerable injury is caused during reperfusion. Topics: Animals; Diphosphates; Dogs; Female; Ischemia; Male; Microscopy, Electron; Muscles; Organ Size; Perfusion; Radionuclide Imaging; Regional Blood Flow; Technetium; Technetium Tc 99m Pyrophosphate; Time Factors | 1988 |
The extent and distribution of skeletal muscle necrosis after graded periods of complete ischemia.
The management of an acutely ischemic extremity requires knowledge of the response of skeletal muscle (the largest component of the lower limb) to prolonged periods of complete normothermic ischemia. We have used the canine gracilis muscle model to evaluate the extent and distribution of ischemic necrosis after 3 and 5 hours of ischemia and 48 hours of reperfusion. Each muscle was cut into six slices, and the extent and distribution of postischemic necrosis identified by means of nitroblue tetrazolium staining and 99mTc pyrophosphate uptake. After 3, 4, and 5 hours of ischemia the extent of necrosis was 2.0% +/- 0.9%, 30.3% +/- 6.0%, and 90.1% +/- 3.5% (mean +/- SEM), respectively. A statistically significant correlation exists between the extent of necrosis and the uptake of 99mTc pyrophosphate uptake per gram of tissue (y = 1574.9x - 8.4, r = 0.84, p less than 0.001). Most necrosis was centrally located and found in the thickest portion of the muscle. We conclude that there is a graded response in the extent of skeletal muscle necrosis related to the length of ischemic stress rather than an "all-or-none" phenomenon. This central distribution of necrosis makes the usual external evaluation of ischemic damage clinically unreliable. In addition, since there was no enveloping fascia in this model, a compartment release alone may not prevent the development of skeletal muscle necrosis. This knowledge of the response of skeletal muscle to ischemia may lead to an improved clinical approach to an extremity suffering a prolonged ischemic insult. Topics: Animals; Diphosphates; Dogs; Ischemia; Muscles; Necrosis; Nitroblue Tetrazolium; Radionuclide Imaging; Technetium; Technetium Tc 99m Pyrophosphate; Time Factors; Ultrasonography; Vascular Patency | 1987 |
Radionuclide scans to define patterns of occult myonecrosis.
Topics: Adult; Arterial Occlusive Diseases; Diphosphates; Humans; Ischemia; Leg; Male; Middle Aged; Radioisotopes; Radionuclide Imaging; Rhabdomyolysis; Technetium; Technetium Tc 99m Pyrophosphate; Thallium | 1986 |
Evaluation of renal ischemia with 99mTc-pyrophosphate.
Renal ischemia injury was induced by transient 30-min occlusion of the main artery in five rabbits and by transient 60-min occlusion in four rabbits. The vessels to the contralateral kidneys were ligated in all nine animals and in six additional control rabbits. Renal blood flow was restored immediately following the transient ischemia. Twenty-four hours later, 99mTc-pyrophosphate was injected and renal uptake was monitored for 100 s and 10-min intervals for 90 min following injection. At 90 min postinjection, the animals were killed and the percent injected dose remaining in the kidneys was calculated for three animals in each group. At 60 min postinjection, in vivo activity in the 30-min ischemic kidneys was 2.3 times greater than that of controls, and activity in the 60-min ischemic kidneys 4.6 times greater than that of controls. These results suggest that 99mTc-pyrophosphate scanning may be useful in assessing slight ischemic damage to the kidney. Topics: Animals; Diphosphates; Ischemia; Kidney; Kidney Tubular Necrosis, Acute; Rabbits; Radionuclide Imaging; Technetium; Technetium Tc 99m Pyrophosphate; Time Factors | 1982 |
Simultaneous display of gated technetium-99m stannous pyrophosphate and gated blood-pool scintigrams.
We have developed a method by which any two sets of R-wave-synchronized radionuclide images may be registered, color-coded, and displayed in cinematic fashion so that the image sets are superimposed and shown simultaneously in contrasting colors. The technique has been applied to technetium-99m stannous pyrophosphate (Tc-99m PPi) and equilibrium blood-pool images. Gated Tc-99m PPi and gated blood-pool image sets (16 frames per cardiac cycle) were acquired in identical projections. Image sets were then registered, if necessary, and color-coded by a computer algorithm. Our initial experience suggests that this overlay technique may be of value to: (a) detect right ventricular infarction with greater precision; (b) provide a better estimate of anatomic location and circumferential extent of Tc-99m PPi myocardial uptake relative to the ventricular blood pool; and (c) distinguish between segmental contraction abnormalities caused by recent infarction (identified by abnormal Tc-99m PPi uptake) and segmental contraction abnormalities caused by ischemia or previous myocardial infarction. Topics: Adult; Aged; Diagnosis, Differential; Female; Heart; Heart Function Tests; Heart Ventricles; Humans; Ischemia; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Myocardium; Polyphosphates; Radionuclide Imaging; Technetium; Technetium Tc 99m Pyrophosphate; Tin Polyphosphates | 1981 |